Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Meloxicam). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Meclam is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
For Adults: Osteoarthritis: 7.5 mg per day, which can be raised to 15 mg per day if it doesn't provide enough improvement. Rheumatoid arthritis: 15 mg per day, though elderly patients should keep to 7.5 mg per day for long-term treatment. Ankylosing spondylitis: 15 mg per day, or 7.5 mg per day in elderly patients. The dose should not go above 15 mg/day, and the full daily amount is taken as a single dose. Adults at higher risk of adverse reactions should begin treatment at 7.5 mg/day, and dialysis patients with severe renal failure should not exceed 7.5 mg/day. For Children: Meloxicam's pharmacokinetics in paediatric patients under 18 years of age have not been studied.
Side Effects
Nausea, vomiting, stomach pain, indigestion, constipation, and diarrhoea can all occur with this medicine. Rarely, it may cause stomach ulcers or gastrointestinal bleeding. Some people may develop a skin rash or hives, and swelling of the lower legs is also possible during treatment. In people who are allergic to aspirin or other NSAIDs, it has been known to trigger an asthma attack. Headache, dizziness, and drowsiness may also occur.
Cautions & Contraindications
Warnings & Precautions
Patients with known cardiovascular disease or CV risk factors, fluid retention or heart failure, or a history of GI bleeding or ulceration. Hepatic and renal impairment. Elderly patients. Pregnancy and lactation.
Contraindications
Meloxicam should not be used by anyone who is hypersensitive to it. It should also be avoided by patients who have developed asthma symptoms, nasal polyps, angioneurotic oedema, or urticaria after taking aspirin or other NSAIDs. It is likewise not recommended for patients with an active peptic ulcer within the past six months or a history of recurrent peptic ulcer disease, severe liver failure, severe kidney failure not managed by dialysis, gastrointestinal bleeding, cerebrovascular bleeding, or other bleeding disorders.